Thomas J. Blacklock

1 Patent

• US116423292023

  Amorphous Solid Form of Compounds Containing S—n-valeryl-n- {[2′-( 1 H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic Acid Ethyl Ester Moieties and Sodium Cations

  Novartis Pharmaceuticals Corporation

  0 cites